"We chose PrEP because I wanted to be sure that this child my wife was going to conceive was indeed mine." Factors influencing the choice of safer conception methods and experiences with its use: a qualitative study among HIV sero-discordant couples in Zimbabwe.
ART
HIV prevention
HIV-discordant couples
LMIC
PrEP
Safer conception
Semen washing
Vaginal insemination
Zimbabwe
sub-Saharan Africa
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
19 Jul 2024
19 Jul 2024
Historique:
received:
12
03
2024
accepted:
14
06
2024
medline:
20
7
2024
pubmed:
20
7
2024
entrez:
19
7
2024
Statut:
epublish
Résumé
Safer conception services are needed to minimize HIV transmission among HIV sero-discordant couples desiring pregnancy. Few studies have evaluated the choices couples make when they are offered multiple safer conception methods or real-world method acceptability. This paper addresses an important knowledge gap regarding factors that influence the choice of safer conception methods, couples' actual experiences using safer conception methods, and why some couples switch safer conception methods. Between February and June 2019, we conducted semi-structured in-depth interviews among 14 men and 17 women, representing 17 couples who exited the SAFER study-a pilot safer conception study for HIV sero-discordant couples in Zimbabwe that offered couples a choice of ART with monthly viral load monitoring (ART/VL), oral PrEP, vaginal insemination, and semen washing. All couples in SAFER had used at least two safer conception methods. We found that safer conception method choice often centered around a desire for intimacy, condomless sex, and certainty in the conception process, particularly for men. Method-related attributes such as familiarity, perceived ease of use, side effects, and perceived level of effectiveness in preventing HIV and achieving pregnancy influenced method choice, switching, and satisfaction. Concerns were expressed about each safer conception method and couples were willing to try different methods until they found method(s) that worked for them. The majority of participants reported having positive experiences using safer conception, especially those using ART/VL + PrEP, citing that they were able to attempt pregnancy for the first time with peace of mind and experienced joy and satisfaction from being able to achieve pregnancy safely. The differences in method preferences and experiences voiced by participants in this study and in other studies from the region point to the importance of having a variety of safer conception options in the service delivery package and addressing concerns about paternity, intimacy, and method-related attributes to enable HIV sero-discordant couples to safely achieve their reproductive goals.
Sections du résumé
BACKGROUND
BACKGROUND
Safer conception services are needed to minimize HIV transmission among HIV sero-discordant couples desiring pregnancy. Few studies have evaluated the choices couples make when they are offered multiple safer conception methods or real-world method acceptability. This paper addresses an important knowledge gap regarding factors that influence the choice of safer conception methods, couples' actual experiences using safer conception methods, and why some couples switch safer conception methods.
METHODS
METHODS
Between February and June 2019, we conducted semi-structured in-depth interviews among 14 men and 17 women, representing 17 couples who exited the SAFER study-a pilot safer conception study for HIV sero-discordant couples in Zimbabwe that offered couples a choice of ART with monthly viral load monitoring (ART/VL), oral PrEP, vaginal insemination, and semen washing. All couples in SAFER had used at least two safer conception methods.
RESULTS
RESULTS
We found that safer conception method choice often centered around a desire for intimacy, condomless sex, and certainty in the conception process, particularly for men. Method-related attributes such as familiarity, perceived ease of use, side effects, and perceived level of effectiveness in preventing HIV and achieving pregnancy influenced method choice, switching, and satisfaction. Concerns were expressed about each safer conception method and couples were willing to try different methods until they found method(s) that worked for them. The majority of participants reported having positive experiences using safer conception, especially those using ART/VL + PrEP, citing that they were able to attempt pregnancy for the first time with peace of mind and experienced joy and satisfaction from being able to achieve pregnancy safely.
CONCLUSIONS
CONCLUSIONS
The differences in method preferences and experiences voiced by participants in this study and in other studies from the region point to the importance of having a variety of safer conception options in the service delivery package and addressing concerns about paternity, intimacy, and method-related attributes to enable HIV sero-discordant couples to safely achieve their reproductive goals.
Identifiants
pubmed: 39030487
doi: 10.1186/s12889-024-19155-9
pii: 10.1186/s12889-024-19155-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1936Informations de copyright
© 2024. The Author(s).
Références
UNAIDS Data 2021, Geneva: Joint United Nations Programme on HIV/AIDS; 2021. Licence: CC BY-NC-SA 3.0 IGO.
Kimemia G, Ngure K, Baeten JM, Celum C, Dew K, Njuguna N, Mugo N, Heffron R. Perceptions of pregnancy occurring among HIV-serodiscordant couples in Kenya. Reprod Health. 2019;16(1):85.
pubmed: 31215447
pmcid: 6582525
doi: 10.1186/s12978-019-0751-4
Taulo F, Berry M, Tsui A, Makanani B, Kafulafula G, Li Q, Nkhoma C, Kumwenda JJ, Kumwenda N, Taha TE. Fertility intentions of HIV-1 infected and uninfected women in Malawi: a longitudinal study. AIDS Behav. 2009;13 Suppl 1:20–7.
pubmed: 19308718
doi: 10.1007/s10461-009-9547-9
Schwartz SR, Mehta SH, Taha TE, Rees HV, Venter F, Black V. High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy. AIDS Behav. 2012;16(1):69–78.
pubmed: 21656145
doi: 10.1007/s10461-011-9981-3
Schwartz SR, Rees H, Mehta S, Venter WD, Taha TE, Black V. High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One. 2012;7(4):e36039.
pubmed: 22558319
pmcid: 3338622
doi: 10.1371/journal.pone.0036039
Tweya H, Feldacker C, Breeze E, Jahn A, Haddad LB, Ben-Smith A, Chaweza T, Phiri S. Incidence of pregnancy among women accessing antiretroviral therapy in urban Malawi: a retrospective cohort study. AIDS Behav. 2013;17(2):471–8.
pubmed: 22354359
doi: 10.1007/s10461-012-0150-0
Chemaitelly H, Cremin I, Shelton J, Hallett TB, Abu-Raddad LJ. Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa. Sex Transm Infect. 2012;88(1):51–7.
pubmed: 22250180
doi: 10.1136/sextrans-2011-050114
Lingappa JR, Lambdin B, Bukusi EA, Ngure K, Kavuma L, Inambao M, Kanweka W, Allen S, Kiarie JN, Makhema J, et al. Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS One. 2008;3(1):e1411.
pubmed: 18183292
pmcid: 2156103
doi: 10.1371/journal.pone.0001411
Dunkle KL, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C, Greenberg L, Allen S. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet. 2008;371(9631):2183–91.
pubmed: 18586173
doi: 10.1016/S0140-6736(08)60953-8
Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai. Uganda J Infect Dis. 2005;191(9):1403–9.
pubmed: 15809897
doi: 10.1086/429411
Beyeza-Kashesya J, Kaharuza F, Mirembe F, Neema S, Ekstrom AM, Kulane A. The dilemma of safe sex and having children: challenges facing HIV sero-discordant couples in Uganda. Afr Health Sci. 2009;9(1):2–12.
pubmed: 20842236
pmcid: 2932519
Matthews LT, Beyeza-Kashesya J, Cooke I, Davies N, Heffron R, Kaida A, Kinuthia J, Mmeje O, Semprini AE, Weber S. Consensus statement: supporting safer conception and pregnancy for men and women living with and affected by HIV. AIDS Behav. 2018;22(6):1713–24.
pubmed: 28501964
doi: 10.1007/s10461-017-1777-7
Ngure K, Mugo N, Celum C, Baeten JM, Morris M, Olungah O, Olenja J, Tamooh H, Shell-Duncan B. A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya. AIDS Care. 2012;24(4):509–16.
pubmed: 22085306
doi: 10.1080/09540121.2011.613911
Brubaker SG, Bukusi EA, Odoyo J, Achando J, Okumu A, Cohen CR. Pregnancy and HIV transmission among HIV-discordant couples in a clinical trial in Kisumu. Kenya HIV Med. 2011;12(5):316–21.
pubmed: 21205129
doi: 10.1111/j.1468-1293.2010.00884.x
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.
pubmed: 22784037
pmcid: 3770474
doi: 10.1056/NEJMoa1108524
Barreiro P, Duerr A, Beckerman K, Soriano V. Reproductive options for HIV-serodiscordant couples. AIDS Rev. 2006;8(3):158–70.
pubmed: 17078486
Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, Mujugira A, Mugo N, Ndase P, Hendrix C, et al. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014;66(3):340–8.
pubmed: 24784763
pmcid: 4059553
doi: 10.1097/QAI.0000000000000172
Mmeje O, Njoroge B, Wekesa P, Murage A, Ondondo RO, van der Poel S, Guze MA, Shade SB, Bukusi EA, Cohan D, et al. Empowering HIV-infected women in low-resource settings: A pilot study evaluating a patient-centered HIV prevention strategy for reproduction in Kisumu, Kenya. PLoS One. 2019;14(3):e0212656.
pubmed: 30840672
pmcid: 6402674
doi: 10.1371/journal.pone.0212656
Zafer M, Horvath H, Mmeje O, van der Poel S, Semprini AE, Rutherford G, Brown J. Effectiveness of semen washing to prevent human immunodeficiency virus (HIV) transmission and assist pregnancy in HIV-discordant couples: a systematic review and meta-analysis. Fertil Steril. 2016;105(3):645–655 e642.
pubmed: 26688556
doi: 10.1016/j.fertnstert.2015.11.028
Joseph Davey D, West S, Umutoni V, Taleghani S, Klausner H, Farley E, Shah R, Madni S, Orewa S, Kottamasu V, et al. A systematic review of the current status of safer conception strategies for HIV affected heterosexual couples in Sub-Saharan Africa. AIDS Behav. 2018;22(9):2916–46.
pubmed: 29869184
doi: 10.1007/s10461-018-2170-x
Department of Health Republic of South Africa. National Clinical Guidelines for Safe Conception and Infertility. Pretoria; 2020.
Davies NE, Matthews LT, Crankshaw TL, Cooper D, Schwartz SR. Supporting HIV prevention and reproductive goals in an HIV-endemic setting: taking safer conception services from policy to practice in South Africa. J Int AIDS Soc. 2017;20(Suppl 1):21271.
pubmed: 28361506
pmcid: 5577693
doi: 10.7448/IAS.20.2.21271
Fakoya A, Lamba H, Mackie N, Nandwani R, Brown A, Bernard E, Gilling-Smith C, Lacey C, Sherr L, Claydon P, et al. British HIV association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 2008. HIV Med. 2008;9(9):681–720.
pubmed: 18983476
doi: 10.1111/j.1468-1293.2008.00634.x
Goggin K, Mindry D, Beyeza-Kashesya J, Finocchario-Kessler S, Wanyenze R, Nabiryo C, Wagner G. “Our hands are tied up”: current state of safer conception services suggests the need for an integrated care model. Health Care Women Int. 2014;35(7–9):990–1009.
pubmed: 24901882
pmcid: 4150838
doi: 10.1080/07399332.2014.920023
Brown JM, Gitome S, Mataveke B, Chirenda T, Matubu A, Chareka G, Chasakara C, Mgodi N, Murombedzi C, Musara P, et al. Preventing HIV and achieving pregnancy among HIV sero-different couples: Pilot study of a safer conception intervention in Zimbabwe. PLoS Glob Public Health. 2023;3(2):e0000796.
pubmed: 36963004
pmcid: 10022125
doi: 10.1371/journal.pgph.0000796
Hancuch K, Baeten J, Ngure K, Celum C, Mugo N, Tindimwebwa E, Heffron R. Team ftPDP: Safer conception among HIV-1 serodiscordant couples in East Africa: understanding knowledge, attitudes, and experiences. AIDS Care. 2018;30(8):973–81.
pubmed: 29455572
pmcid: 6095140
doi: 10.1080/09540121.2018.1437251
Heffron R, Ngure K, Velloza J, Kiptinness C, Quame-Amalgo J, Oluch L, Thuo N, Njoroge J, Momanyi R, Gakuo S, et al. Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness. J Int AIDS Soc. 2019;22(4):e25261.
pubmed: 30957420
pmcid: 6452026
doi: 10.1002/jia2.25261
Kaggiah A, Kimemia G, Moraa H, Muiruri P, Kinuthia J, Roxby AC. Experiences with safer conception services for HIV-serodiscordant couples at a referral hospital in Nairobi. Kenya Front Reprod Health. 2021;3:693429.
pubmed: 36304040
doi: 10.3389/frph.2021.693429
Schwartz SR, Bassett J, Mutunga L, Yende N, Mudavanhu M, Phofa R, Sanne I, Van Rie A. HIV incidence, pregnancy, and implementation outcomes from the Sakh’umndeni safer conception project in South Africa: a prospective cohort study. Lancet HIV. 2019;6(7):e438–46.
pubmed: 31160268
pmcid: 6660144
doi: 10.1016/S2352-3018(19)30144-4
Wagner GJ, Linnemayr S, Goggin K, Mindry D, Beyeza-Kashesya J, Finocchario-Kessler S, Robinson E, Birungi J, Wanyenze RK. Prevalence and correlates of use of safer conception methods in a prospective cohort of Ugandan HIV-affected couples with fertility intentions. AIDS Behav. 2017;21(8):2479–87.
pubmed: 28229244
pmcid: 5536997
doi: 10.1007/s10461-017-1732-7
Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17(1):88.
pubmed: 28126032
pmcid: 5267473
doi: 10.1186/s12913-017-2031-8
Bernard LC, Krupat E. Health psychology: Biopsychosocial factors in health and illness. Harcourt Brace College Publishers; 1994.
Brown J, Njoroge B, Akama E, Breitnauer B, Leddy A, Darbes L, Omondi R, Mmeje O. A novel safer conception counseling toolkit for the prevention of HIV: a mixed-methods evaluation in Kisumu. Kenya AIDS Educ Prev. 2016;28(6):524–38.
pubmed: 27925487
doi: 10.1521/aeap.2016.28.6.524
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.
pubmed: 17872937
doi: 10.1093/intqhc/mzm042
Ngure K, Kimemia G, Dew K, Njuguna N, Mugo N, Celum C, Baeten JM, Heffron R. Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples. J Int AIDS Soc. 2017;20(Suppl 1):21309.
pubmed: 28361508
pmcid: 5577704
doi: 10.7448/IAS.20.2.21309
Govender E, Abdool Karim Q. Understanding women and men’s acceptability of current and new HIV prevention technologies in KwaZulu-Natal. South Africa AIDS Care. 2018;30(10):1311–4.
pubmed: 29914270
doi: 10.1080/09540121.2018.1488027
Mbewe L, Govender E. Male partners’ influence on women’s acceptance and use of PrEP products across two high HIV-burdened districts in South Africa. Afr J AIDS Res. 2020;19(2):93–100.
pubmed: 32320329
doi: 10.2989/16085906.2020.1727932
Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, Laborde N, Soto-Torres L. Male partner influence on women’s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of “Understanding.” AIDS Behav. 2015;19(5):784–93.
pubmed: 25416076
pmcid: 4416996
doi: 10.1007/s10461-014-0950-5
Musara P, Hartmann M, Ryan JH, Reddy K, Ggita J, Mutero P, Macagna N, Taulo F, Mgodi NM, Piper J, et al. Understanding the role of men in women’s use of the vaginal ring and oral PrEP during pregnancy and breastfeeding: multi-stakeholder perspectives. Afr J AIDS Res. 2022;21(4):354–63.
pubmed: 36538544
pmcid: 9983781
doi: 10.2989/16085906.2022.2138474
Mathenjwa M, Khidir H, Milford C, Mosery N, Rambally Greener L, Pratt MC, O’Neil K, Harrison A, Bangsberg DR, Safren SA, et al. Acceptability of an intervention to promote viral suppression and serostatus disclosure for men living with HIV in South Africa: qualitative findings. AIDS Behav. 2022;26(1):1–12.
pubmed: 34097209
doi: 10.1007/s10461-021-03278-w
Gray A, Smit J, Manzini N, Beksinska M. Systematic review of contraceptive medicines. Does choice make a difference? Johannesberg: University of Witwatersrand; 2006.
Schivone GB, Glish LL. Contraceptive counseling for continuation and satisfaction. Curr Opin Obstet Gynecol. 2017;29(6):443–8.
pubmed: 28938374
doi: 10.1097/GCO.0000000000000408
Schwartz S, West N, Phofa R, Yende N, Sanne I, Bassett J, Van Rie A. Acceptability and preferences for safer conception HIV prevention strategies: A qualitative study. Int J STD AIDS. 2016;27(11):984–92.
pubmed: 26384950
doi: 10.1177/0956462415604091
Velloza J, Ngure K, Kiptinness C, Quame-Amaglo J, Thuo N, Dew K, Kimani M, Gakuo S, Unger J, Kolko B, et al. A clinic-based tablet application to support safer conception among HIV serodiscordant couples in Kenya: feasibility and acceptability study. Mhealth. 2019;14(5):4.
doi: 10.21037/mhealth.2019.01.04
Wagner GJ, Wanyenze RK, Beyeza-Kashesya J, Gwokyalya V, Hurley E, Mindry D, Finocchario-Kessler S, Nanfuka M, Tebeka MG, Saya U, et al. “Our Choice” improves use of safer conception methods among HIV serodiscordant couples in Uganda: a cluster randomized controlled trial evaluating two implementation approaches. Implement Sci. 2021;16(1):41.
pubmed: 33858462
pmcid: 8048255
doi: 10.1186/s13012-021-01109-z